510(K) CLEARANCES 84 ▲14RECALLS POSTED 39 ▲27CLASS I 6 ▲2PMA DECISIONS 47 ▲11WEEK ENDING / FDA DATA AS OF
Medical Device
ManufacturingTHE TRADE PAPER OF THE FACTORY FLOOR
SUBSCRIBE / SIGN IN
K934516Substantially Equivalent

Advance Pregnancy Test Modification

Ortho Pharmaceutical Corp., Raritan NJ / Traditional, Substantially Equivalent
FDA source (opens on fda.gov)

K934516 is the FDA 510(k) clearance record for ADVANCE PREGNANCY TEST MODIFICATION, a class II device, cleared for Ortho Pharmaceutical Corp. on under FDA product code LCX (Kit, Test, Pregnancy, Hcg, Over The Counter). FDA records list 9 510(k) clearances for Ortho Pharmaceutical Corp., from to . As of , FDA records show no recalls naming K934516.

Clearance record

Decision date
Received
(160 days to decision)
Product code
LCX Kit, Test, Pregnancy, Hcg, Over The Counter
Regulation
21 CFR 862.1155
Device class
Class II
Review panel
Clinical Chemistry
Applicant
Ortho Pharmaceutical Corp. Rte. 202, P.O. Box 300, Raritan NJ
510(k) summary
Summary
Third party review
No

Clearances, product code LCX

Trailing 12 months

FDA records hold no clearances under product code LCX in the trailing twelve months.

FDA records show no clearances under product code LCX in the twelve months to October 2026.
Show the numbers
Monthly 510(k) clearances under FDA product code LCX, trailing twelve months
MonthClearances
November 20250
December 20250
January 20260
February 20260
March 20260
April 20260
May 20260
June 20260
July 20260
August 20260
September 20260
October 20260